Diagnostic modality |
Elapsed time since cancer diagnosis (April 2019) |
Findings |
Non-contrast CT of the lumbar spine |
31 months |
New hypodense L5 lesion measuring 18.7×12.6×12 mm (see Figure 2) |
Bone scana
|
32 months |
Mildly increased uptake in the left side of L5 corresponding to the lesion seen on CT (see Figure 3A) |
18F-FDG PET-CT |
33 months |
Mildly hypermetabolic L5 lesion corresponding to the lesion seen on CT (see Figure 4) |
CT-guided FNA |
33.5 months |
Fibrin, scattered inflammatory cells, and no neoplastic findings |
Non-contrast CT of the lumbar spine |
47 months |
Marked interval expansion of the hypodense L5 lesion, now measuring 30.4×22.6×13.8 mm; new hypodense L4 lesion measuring 4×13.9×4.3 mm (see Figure 6) |
Bone scana
|
47 months |
Increased uptake in the left side of L5, stable from prior exam; mildly increased uptake in the inferior margin of L4, adjacent to the L5 lesion (see Figure 3B) |
CT-guided FNA |
47.5 months |
Non-diagnostic specimen |
CT-guided CNB |
47.5 months |
Fibrous tissue, benign bone, and no neoplastic findings |
CT-guided BMA |
47.5 months |
No evidence of clonality |
Laboratory panelb
|
48.5 months |
Within normal limits |
CT-guided CNB |
49 months |
Benign bone remodeling and fibrocartilage; bacterial and fungal cultures of this specimen demonstrated no growth |
Open biopsy |
50 months |
Benign-appearing disorganized fibrocartilage, consistent with Schmorl’s node (see Figure 7) |